Non-nutritive sweeteners in breast milk: perspective on potential implications of recent findings

Archives of Toxicology

Volumn 89, Issue 11, 2015, Pages 2169-2171

  Rother, Kristina I ^a   Sylvetsky, Allison C ^a,b   Schiffman, S S ^c  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c North Carolina State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACESULFAME; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; MULTIDRUG RESISTANCE PROTEIN; NONNUTRITIVE SWEETENER; SACCHARIN; SUCRALOSE; ACETOSULFAME; SUCROSE; THIAZINE DERIVATIVE; TRICHLOROSUCROSE;

BLOOD BRAIN BARRIER; BREAST MILK; ENVIRONMENTAL EXPOSURE; FECES; FOOD INTAKE; FOOD PREFERENCE; GLUCOSE BRAIN LEVEL; HUMAN; INFANT FEEDING; INTESTINE ABSORPTION; LACTATION; LETTER; NONHUMAN; PRIORITY JOURNAL; RECOGNITION; TASTE ACUITY; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; FEMALE; METABOLISM;

ANIMALS; FEMALE; HUMANS; LACTATION; MILK, HUMAN; NON-NUTRITIVE SWEETENERS; SACCHARIN; SUCROSE; THIAZINES;

EID: 84947616393     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-015-1611-9     Document Type: Letter

References (24)

1. Abou-Donia MB, El-Masry EM, Abdel- Rahman AA, McLendon RE, Schiffman SS (2008) Splenda alters gut microflora and increases intestinal P-glycoprotein and cytochrome P-450 in male rats. J Toxicol Environ Health A 71:1415–1429
2. Abu-Qare AW, Elmasry E, Abou-donia MB (2003) A role for P-glycoprotein in environmental toxicology. J Toxicol Environ Health B 6:279–288
3. Alcorn J, McNamara PJ (2002) Ontogeny of hepatic and renal systemic clearance pathways in infants: part I. Clin Pharmacokinet 41:959–998
4. Balayssac D, Authier N, Cayre A, Coudore F (2005) Does inhibition of P-glycoprotein lead to drug–drug interactions? Toxicol Lett 156:319–329
5. Doré J, Blottière H (2015) The influence of diet on the gut microbiota and its consequences for health. Curr Opin Biotechnol 32:195–199
6. Flockhart DA (2007) Drug interactions: cytochrome P450 drug interaction table. Indiana University School of Medicine. http://medicine.iupui.edu/clinpharm/ddis/clinical-table. Accessed 31 Aug 2015
7. Grice HC, Goldsmith LA (2000) Sucralose—an overview of the toxicity data. Food Chem Toxicol 38(Suppl 2):S1–S6
8. Iscan M, Klaavuniemi T, Coban T, Kapucuoglu N, Pelkonen O, Raunio H (2001) The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissue. Breast Cancer Res Treat 70:47–54
9. Lacroix D, Sonnier M, Moncion A, Cheron G, Cresteil T (1997) Expression of CYP3A in the human liver—evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur J Biochem 247:625–634
10. Lam J, Koren G (2014) P-glycoprotein in the developing human brain: a review of the effects of ontogeny on the safety of opioids in neonates. Ther Drug Monit 36:699–705
11. Mennella JA (2014) Ontogeny of taste preferences: basic biology and implications for health. Am J Clin Nutr 99(Suppl):704S–711S
12. Nylund L, Satokari R, Salminen S, de Vos WM (2014) Intestinal microbiota during early life—impact on health and disease. Proc Nutr Soc 73:457–469
13. Ren X, Zhou L, Terwilliger R, Newton SS, de Araujo IE (2009) Sweet taste signaling functions as a hypothalamic glucose sensor. Front Integr Neurosci 3:12
14. Rhodin MM, Anderson BJ, Peters AM, Coulthard MG, Wilkins B, Cole M, Chatelut E, Grubb A, Veal GJ, Keir MJ, Holford NH (2009) Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol 24:67–76
15. Rosenbaum M, Knight R, Leibel RL (2015) The gut microbiota in human energy homeostasis and obesity. Trends Endocrinol Metab 26:493–501
16. Schiffman SS (2012) Rationale for further medical and health research on high-potency sweeteners. Chem Senses 37:671–679
17. Schiffman SS, Rother KI (2013) Sucralose, a synthetic organochlorine sweetener: overview of biological issues. J Toxicol Environ Health B Crit Rev 16:399–451
18. Schiffman SS, Booth BJ, Carr BT, Losee ML, Sattely-Miller EA, Graham BG (1995) Investigation of synergism in binary mixtures of sweeteners. Brain Res Bull 38:105–120
19. Schiffman SS, Sattely-Miller EA, Bishay IE (2008) Sensory properties of neotame: comparison with other sweeteners. In: Weerasinghe DK, Dubois, GE (eds) Sweetness and sweeteners: biology, chemistry and psychophysics. ACS symposium series. Oxford University Press, pp 511–529
20. Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, Israeli D, Zmora N, Gilad S, Weinberger A, Kuperman Y, Harmelin A, Kolodkin-Gal I, Shapiro H, Halpern Z, Segal E, Elinav E (2014) Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514:181–186
21. Swithers SE (2013) Artificial sweeteners produce the counterintuitive effect of inducing metabolic derangements. Trends Endocrinol Metab 24:431–441
22. Sylvetsky AC, Gardner AL, Bauman V, Blau JE, Garraffo HM, Walter PJ, Rother KI (2015) Nonnutritive sweeteners in breast milk. J Toxicol Environ Health A 78:1029–1032
23. Tilg H, Kaser A (2011) Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest 121:2126–2132
24. Zhang GH, Chen ML, Liu SS, Zhan YH, Quan Y, Qin YM, Deng SP (2011) Effects of mother’s dietary exposure to acesulfame-K in pregnancy or lactation on the adult offspring’s sweet preference. Chem Senses 36:763–770